These differences in TXNIP KO effect on T cell tumor control correlated with anti-PD-1 responsiveness status, donors 1 and 2 being anti-PD-1 responsive while donors 3 and 4 were not (Supplementary Figures S6E, F). The gene discussed is TXNIP; the disease is neoplasm.